Hippocampal proliferation is increased in presymptomatic parkinson's disease and due to microglia

Neural Plasticity

Volumn 2014, Issue , 2014, Pages

  Doorn, Karlijn J ^a,b   Drukarch, Benjamin ^b   Van Dam, Anne Marie ^b   Lucassen, Paul J ^a  

^a UNIVERSITY OF AMSTERDAM   (Netherlands)

^b VU UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA SYNUCLEIN; MINICHROMOSOME MAINTENANCE PROTEIN 2;

ADULT; AGED; ARTICLE; BRAIN REGION; BRAIN TISSUE; CELL PROLIFERATION; CELLULAR DISTRIBUTION; CLINICAL ARTICLE; CLINICAL ASSESSMENT; CONTROLLED STUDY; DENTATE HILUS; DIFFUSE LEWY BODY DISEASE; FEMALE; GLIA CELL; HIPPOCAMPAL CA3 REGION; HIPPOCAMPUS; HUMAN; HUMAN TISSUE; IMMUNOCYTOCHEMISTRY; MALE; MICROGLIA; NERVOUS SYSTEM INFLAMMATION; NEUROPATHOLOGY; PARKINSON DISEASE; PRODROMAL SYMPTOM; SUBSTANTIA NIGRA; SUBVENTRICULAR ZONE; METABOLISM; PATHOLOGY; PATHOPHYSIOLOGY; PHYSIOLOGY; VERY ELDERLY;

AGED; AGED, 80 AND OVER; ALPHA-SYNUCLEIN; CELL PROLIFERATION; FEMALE; HIPPOCAMPUS; HUMANS; MALE; MICROGLIA; PARKINSON DISEASE; PRODROMAL SYMPTOMS;

EID: 84907390827     PISSN: 20905904     EISSN: 16875443     Source Type: Journal    
DOI: 10.1155/2014/959154     Document Type: Article

References (88)

1. G. Alves, E. B. Forsaa, K. F. Pedersen, M. Dreetz Gjerstad, and J. P. Larsen, "Epidemiology of Parkinson's disease," Journal of Neurology, vol. 255, no. 5, pp. 18-32, 2008.
2. D. Aarsland and M. W. Kurz, "The epidemiology of dementia associated with Parkinson's disease," Brain Pathology, vol. 20, no. 3, pp. 633-639, 2010.
3. A. Gaenslen, I. Swid, I. Liepelt-Scarfone, J. Godau, and D. Berg, "The patients' perception of prodromal symptoms before the initial diagnosis of Parkinson's disease," Movement Disorders, vol. 26, no. 4, pp. 653-658, 2011.
4. L. T. Grinberg, U. Rueb, A. T. D. L. Alho, and H. Heinsen, "Brainstem pathology and non-motor symptoms in PD," Journal of the Neurological Sciences, vol. 289, no. 1-2, pp. 81-88, 2010.
5. H. Braak, U. Rüb, and K. Del Tredici, "Cognitive decline correlates with neuropathological stage in Parkinson's disease," Journal of the Neurological Sciences, vol. 248, no. 1-2, pp. 255-258, 2006.
6. H. Braak, K. Del Tredici, H. Bratzke, J. Hamm-Clement, D. Sandmann-Keil, and U. Rüb, "Staging of the intracerebral inclusion body pathology associated with idiopathic Parkinson's disease (preclinical and clinical stages)," Journal of Neurology, vol. 249, supplement 3, pp. 1-5, 2002.
7. W. D. J. van de Berg, D. H. Hepp, A. A. Dijkstra, J. A. M. Rozemuller, H.W. Berendse, and E. Foncke, "Patterns of alpha-synuclein pathology in incidental cases and clinical subtypes of Parkinson's disease," Parkinsonism & Related Disorders, vol. 18, no. 1, pp. S28-S30, 2012.
8. D. C. Wu, V. Jackson-Lewis, M. Vila et al., "Blockade of microglial activation is neuroprotective in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine mouse model of Parkinson disease," The Journal of Neuroscience, vol. 22, no. 5, pp. 1763-1771, 2002.
9. K. J. Doorn, P. J. Lucassen, H. W. Boddeke et al., "Emerging roles of microglial activation and non-motor symptoms in Parkinson's disease," Progress in Neurobiology, vol. 98, no. 2, pp. 222-238, 2012.
10. W. Zhang, T. Wang, Z. Pei et al., "Aggregated α-synuclein activates microglia: a process leading to disease progression in Parkinson's disease," The FASEB Journal, vol. 19, no. 6, pp. 533-542, 2005.
11. Y. Lim, V. M. Kehm, E. B. Lee et al., "α-syn suppression reverses synaptic and memory defects in a mouse model of dementia with lewy bodies," The Journal of Neuroscience, vol. 31, no. 27, pp. 10076-10087, 2011.
12. G. A. Carlesimo, F. Piras, F. Assogna, F. E. Pontieri, C. Caltagirone, and G. Spalletta, "Hippocampal abnormalities and memory deficits in Parkinson disease: a multimodal imaging study," Neurology, vol. 78, no. 24, pp. 1939-1945, 2012.
13. B. Winner, D. C. Lie, E. Rockenstein et al., "Human wild-type α-synuclein impairs neurogenesis," Journal of Neuropathology and Experimental Neurology, vol. 63, no. 11, pp. 1155-1166, 2004.
14. P. Desplats, B. Spencer, L. Crews et al., "α-Synuclein induces alterations in adult neurogenesis in Parkinson disease models via p53-mediated repression of notch," Journal of Biological Chemistry, vol. 287, no. 38, pp. 31691-31702, 2012.
15. B.Winner, Z. Kohl, and F. H. Gage, "Neurodegenerative disease and adult neurogenesis," European Journal of Neuroscience, vol. 33, no. 6, pp. 1139-1151, 2011.
16. B. Winner, M. Geyer, S. Couillard-Despres et al., "Striatal deafferentation increases dopaminergic neurogenesis in the adult olfactory bulb," Experimental Neurology, vol. 197, no. 1, pp. 113-121, 2006.
17. K. Suzuki, K. Okada, T.Wakuda et al., "Destruction of dopaminergic neurons in the midbrain by 6-hydroxydopamine decreases hippocampal cell proliferation in rats: reversal by fluoxetine," PLoS ONE, vol. 5, no. 2, Article ID e9260, 2010.
18. G. H. Liu, J. Qu, K. Suzuki et al., "Progressive degeneration of human neural stemcells caused by pathogenic LRRK2," Nature, vol. 491, no. 7425, pp. 603-607, 2012.
19. P. Desplats, P. Patel, K. Kosberg et al., "Combined exposure to Maneb and Paraquat alters transcriptional regulation of neurogenesis-related genes in mice models of Parkinsons disease," Molecular Neurodegeneration, vol. 7, no. 1, article 49, 2012.
20. Z. Kohl, B.Winner, K. Ubhi et al., "Fluoxetine rescues impaired hippocampal neurogenesis in a transgenic A53T synuclein mouse model," European Journal of Neuroscience, vol. 35, no. 1, pp. 10-19, 2012.
21. G. M. Petzinger, B. E. Fisher, S. McEwen, J. A. Beeler, J. P. Walsh, and M.W. Jakowec, "Exercise-enhanced neuroplasticity targeting motor and cognitive circuitry in Parkinson's disease," The Lancet Neurology, vol. 12, no. 7, pp. 716-726, 2013.
22. O. Lamm, J. Ganz, E. Melamed, and D. Offen, "Harnessing neurogenesis for the possible treatment of Parkinson's disease," Journal of Comparative Neurology, vol. 522, no. 12, pp. 2817-2830, 2014.
23. M. W. Marlatt and P. J. Lucassen, "Neurogenesis and Alzheimer's disease: biology and pathophysiology in mice and men," Current Alzheimer Research, vol. 7, no. 2, pp. 113-125, 2010.
24. C.D. Clelland, M. Choi, C. Romberg et al., "A functional role for adult hippocampal neurogenesis in spatial pattern separation," Science, vol. 325, no. 5937, pp. 210-213, 2009.
25. G. C. O'Keeffe, R. A. Barker, and M. A. Caldwell, "Dopaminergic modulation of neurogenesis in the subventricular zone of the adult brain," Cell Cycle, vol. 8, no. 18, pp. 2888-2894, 2009.
26. F. Marxreiter, M. Regensburger, and J. Winkler, "Adult neurogenesis in Parkinson's disease," Cellular and Molecular Life Sciences, vol. 70, no. 3, pp. 459-473, 2013.
27. K. Yoshimi, Y. Ren, T. Seki et al., "Possibility for neurogenesis in substantia nigra of parkinsonian brain," Annals of Neurology, vol. 58, no. 1, pp. 31-40, 2005.
28. A. Borta and G. U. Höglinger, "Dopamine and adult neurogenesis," Journal of Neurochemistry, vol. 100, no. 3, pp. 587-595, 2007.
29. G. U. Höglinger, P. Rizk, M. P. Muriel et al., "Dopamine depletion impairs precursor cell proliferation in Parkinson disease," Nature Neuroscience, vol. 7, no. 7, pp. 726-735, 2004.
30. S. A. van den Berge, M. E. van Strien, J. A. Korecka et al., "The proliferative capacity of the subventricular zone is maintained in the parkinsonian brain," Brain, vol. 134, no. 11, pp. 3249-3263, 2011.
31. O. Arias-Carrión, E. Yamada, N. Freundlieb et al., "Neurogenesis in substantia nigra of parkinsonian brains?" Journal ofNeural Transmission. Supplementum, no. 73, pp. 279-285, 2009.
32. G. U. Höglinger, R. A. Barker, T. Hagg, O. Arias-Carrión, M. A. Caldwell, and E. C. Hirsch, "Quantitative evaluation of the human subventricular zone," Brain, vol. 135, no. 8, p. e221, 2012.
33. S. A. Van Den Berge, M. E. Van Strien, J. A. Korecka et al., "Reply: Quantitative evaluation of the human subventricular zone," Brain, vol. 135, no. 8, p. e222, 2012.
34. M. Zhao, S. Momma, K. Delfani et al., "Evidence for neurogenesis in the adult mammalian substantia nigra," Proceedings of the National Academy of Sciences of the United States of America, vol. 100, no. 13, pp. 7925-7930, 2003.
35. Z. Ding, V. Mathur, P. P. Ho et al., "Antiviral drug ganciclovir is a potent inhibitor of microglial proliferation and neuroinflammation," The Journal of Experimental Medicine, vol. 211, pp. 189-198, 2014.
36. M. W. Marlatt, J. Bauer, E. Aronica et al., "Proliferation in the Alzheimer hippocampus is due to microglia, not astroglia, and occurs at sites of amyloid deposition," Neural Plasticity. Inpress.
37. K. Imamura, N. Hishikawa, K. Ono et al., "Cytokine production of activated microglia and decrease in neurotrophic factors of neurons in the hippocampus of Lewy body disease brains," Acta Neuropathologica, vol. 109, no. 2, pp. 141-150, 2005.
38. R. M. Z. Reena, M.Mastura, M. A. Siti-Aishah et al., "Minichromosome maintenance protein 2 is a reliable proliferativemarker in breast carcinoma," Annals of Diagnostic Pathology, vol. 12, no. 5, pp. 340-343, 2008.
39. P. J. Lucassen, M. W. Stumpel, Q. Wang, and E. Aronica, "Decreased numbers of progenitor cells but no response to antidepressant drugs in the hippocampus of elderly depressed patients," Neuropharmacology, vol. 58, no. 6, pp. 940-949, 2010.
40. O. Von Bohlen Und Halbach, "Immunohistological markers for staging neurogenesis in adult hippocampus," Cell and Tissue Research, vol. 329, no. 3, pp. 409-420, 2007.
41. K. Boekhoorn, M. Joels, and P. J. Lucassen, "Increased proliferation reflects glial and vascular-associated changes, but not neurogenesis in the presenile Alzheimer hippocampus," Neurobiology of Disease, vol. 24, no. 1, pp. 1-14, 2006.
42. O. Von Bohlen und Halbach, "Immunohistological markers for proliferative events, gliogenesis, and neurogenesis within the adult hippocampus," Cell and Tissue Research, vol. 345, no. 1, pp. 1-19, 2011.
43. K. Hashimoto, K. Araki, M. Osaki et al., "MCM2 and Ki-67 expression in human lung adenocarcinoma: prognostic implications," Pathobiology, vol. 71, no. 4, pp. 193-200, 2004.
44. A. Fahrner, G. Kann, A. Flubacher et al., "Granule cell dispersion is not accompanied by enhanced neurogenesis in temporal lobe epilepsy patients," Experimental Neurology, vol. 203, no. 2, pp. 320-332, 2007.
45. S. Bruno and Z. Darzynkiewicz, "Cell cycle dependent expression and stability of the nuclear protein detected by Ki-67 antibody in HL-60 cells," Cell Proliferation, vol. 25, no. 1, pp. 31-40, 1992.
46. A. Y. Maslov, T. A. Barone, R. J. Plunkett, and S. C. Pruitt, "Neural stem cell detection, characterization, and age-related changes in the subventricular zone of mice," Journal of Neuroscience, vol. 24, no. 7, pp. 1726-1733, 2004.
47. Y. Saka and J. C. Smith, "Spatial and temporal patterns of cell division during early Xenopus embryogenesis," Developmental Biology, vol. 229, no. 2, pp. 307-318, 2001.
48. P. S. Eriksson, E. Perfilieva, T. Björk-Eriksson et al., "Neurogenesis in the adult human hippocampus," Nature Medicine, vol. 4, no. 11, pp. 1313-1317, 1998.
49. M. S. Rao, B. Hattiangady, and A. K. Shetty, "The window and mechanisms of major age-related decline in the production of new neurons within the dentate gyrus of the hippocampus," Aging Cell, vol. 5, no. 6, pp. 545-558, 2006.
50. V. Vedam-Mai, B. Gardner, M. S. Okun et al., "Increased precursor cell proliferation after deep brain stimulation for Parkinson's disease: a human study," PloS ONE, vol. 9, Article ID e88770, 2014.
51. D. R. Kornack and P. Rakic, "Continuation of neurogenesis in the hippocampus of the adult macaque monkey," Proceedings of the National Academy of Sciences of the United States of America, vol. 96, no. 10, pp. 5768-5773, 1999.
52. K. Stiasny-Kolster, Y. Doerr, J. C. Möller et al., "Combination of "idiopathic" REM sleep behaviour disorder and olfactory dysfunction as possible indicator for α-synucleinopathy demonstrated by dopamine transporter FP-CIT-SPECT," Brain, vol. 128, no. 1, pp. 126-137, 2005.
53. U. Sommer, T. Hummel, K. Cormann et al., "Detection of presymptomatic Parkinson's disease: combining smell tests, transcranial sonography, and SPECT," Movement Disorders, vol. 19, no. 10, pp. 1196-1202, 2004.
54. E. Bezard, S. Dovero, C. Prunier et al., "Relationship between the appearance of symptoms and the level of nigrostriatal degeneration in a progressive 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-lesioned macaque model of Parkinson's disease," Journal of Neuroscience, vol. 21, no. 17, pp. 6853-6861, 2001.
55. K. Herrup and Y. Yang, "Cell cycle regulation in the postmitotic neuron: oxymoron or new biology?" Nature Reviews Neuroscience, vol. 8, no. 5, pp. 368-378, 2007.
56. A. J. Harding and G. M. Halliday, "Cortical Lewy body pathology in the diagnosis of dementia," Acta Neuropathologica, vol. 102, no. 4, pp. 355-363, 2001.
57. R. A. Armstrong, P. T. Kotzbauer, J. S. Perlmutter et al., "A quantitative study of α-synuclein pathology in fifteen cases of dementia associated with Parkinson disease," Journal of Neural Transmission, vol. 121, no. 2, pp. 171-181, 2014.
58. H. M. Gao and J. S. Hong, "Why neurodegenerative diseases are progressive: uncontrolled inflammation drives disease progression," Trends in Immunology, vol. 29, no. 8, pp. 357-365, 2008.
59. K. J. Doorn, A. Goudriaan, C. Blits-Huizinga et al., "Increased amoeboid microglial density in the olfactory bulb of Parkinson's and Alzheimer's patients," Brain Pathology, vol. 24, no. 2, pp. 152-165, 2014.
60. P. L. McGeer and E. G. McGeer, "Glial reactions in Parkinson's disease," Movement Disorders, vol. 23, no. 4, pp. 474-483, 2008.
61. K. J. Doorn, T. Moors, B. Drukarch, W. D. J. van de Berg, P. J. Lucassen, and A.-M. van Dam, "Microglial phenotypes and Toll-like receptor 2 in the substantia nigra and hippocampus of incidental Lewy body disease cases and Parkinson's disease patients," Acta Neuropathologica Communications, vol. 2, article 90, 2014.
62. B.Winner, M. Regensburger, S. Schreglmann et al., "Role of α-synuclein in adult neurogenesis and neuronalmaturation in the dentate gyrus," The Journal of Neuroscience, vol. 32, no. 47, pp. 16906-16916, 2012.
63. L. Crews, H. Mizuno, P. Desplats et al., "α-synuclein alters Notch-1 expression and neurogenesis in mouse embryonic stem cells and in the hippocampus of transgenic mice," The Journal of Neuroscience, vol. 28, no. 16, pp. 4250-4260, 2008.
64. L. J. Lawson, V. H. Perry, and S. Gordon, "Turnover of resident microglia in the normal adult mouse brain," Neuroscience, vol. 48, no. 2, pp. 405-415, 1992.
65. M. Prinz and A. Mildner, "Microglia in the CNS: immigrants from another world," Glia, vol. 59, no. 2, pp. 177-187, 2011.
66. D. Gómez-Nicola, N. L. Fransen, S. Suzzi, and V. Hugh Perry, "Regulation of microglial proliferation during chronic neurodegeneration," Journal of Neuroscience, vol. 33, no. 6, pp. 2481-2493, 2013.
67. W. Kamphuis, M. Orre, L. Kooijman, M. Dahmen, and E. M. Hol, "Differential cell proliferation in the cortex of the APPswePS1dE9 Alzheimer's disease mouse model," Glia, vol. 60, no. 4, pp. 615-629, 2012.
68. X. Su, K. A. Maguire-Zeiss, R.Giuliano, L. Prifti, K. Venkatesh, and H. J. Federoff, "Synuclein activates microglia in a model of Parkinson's disease," Neurobiology of Aging, vol. 29, no. 11, pp. 1690-1701, 2008.
69. C. Kim, D. Ho, J. Suk et al., "Neuron-released oligomeric α-synuclein is an endogenous agonist of TLR2 for paracrine activation of microglia," Nature Communications, vol. 4, article 1562, 2013.
70. G. Codolo, N. Plotegher, T. Pozzobon et al., "Triggering of inflammasome by aggregated α-synuclein, an inflammatory response in synucleinopathies," PLoS ONE, vol. 8, no. 1, Article ID e55375, 2013.
71. C. W. Olanow and P. Brundin, "Parkinson's disease and α synuclein: is Parkinson's disease a prion-like disorder?" Movement Disorders, vol. 28, no. 1, pp. 31-40, 2013.
72. M. Polymenidou and D. W. Cleveland, "Prion-like spread of protein aggregates in neurodegeneration," Journal of Experimental Medicine, vol. 209, no. 5, pp. 889-893, 2012.
73. H. Braak, K. del Tredici, U. Rüb, R. A. I. de Vos, E. N. H. Jansen Steur, and E. Braak, "Staging of brain pathology related to sporadic Parkinson's disease," Neurobiology of Aging, vol. 24, no. 2, pp. 197-211, 2003.
74. E. C. Hirsch, S. Vyas, and S. Hunot, "Neuroinflammation in Parkinson's disease," Parkinsonism and Related Disorders, vol. 18, no. 1, pp. S210-S212, 2012.
75. H. J. Lee, J. E. Suk, E. J. Bae, and S. J. Lee, "Clearance and deposition of extracellular alpha-synuclein aggregates in microglia," Biochemical and Biophysical Research Communications, vol. 372, no. 3, pp. 423-428, 2008.
76. A. D. Reynolds, J. G. Glanzer, I. Kadiu et al., "Nitrated alpha-synuclein-activated microglial profiling for Parkinson's disease," Journal of Neurochemistry, vol. 104, no. 6, pp. 1504-1525, 2008.
77. S. Walter, M. Letiembre, Y. Liu et al., "Role of the toll-like receptor 4 in neuroinflammation in Alzheimer's disease," Cellular Physiology and Biochemistry, vol. 20, no. 6, pp. 947-956, 2007.
78. C. K. Glass, K. Saijo, B. Winner, M. C. Marchetto, and F. H. Gage, "Mechanisms underlying inflammation in neurodegeneration," Cell, vol. 140, no. 6, pp. 918-934, 2010.
79. E. G. Reed-Geaghan, J. C. Savage, A. G. Hise, and G. E. Landreth, "CD14 and toll-like receptors 2 and 4 are required for fibrillar Aβ-stimulated microglial activation," The Journal of Neuroscience, vol. 29, no. 38, pp. 11982-11992, 2009.
80. B. Brawek, B. Schwendele, K. Riester et al., "Impairment of in vivo calciumsignaling in amyloid plaque-associated microglia," Acta Neuropathologica, vol. 127, no. 4, pp. 495-505, 2014.
81. S. A. Baker, K. A. Baker, and T. Hagg, "Dopaminergic nigrostriatal projections regulate neural precursor proliferation in the adult mouse subventricular zone," European Journal of Neuroscience, vol. 20, no. 2, pp. 575-579, 2004.
82. G. U. Hoglinger, O. Arias-Carrión, B. Ipach, and W. H. Oertel, "Origin of the dopaminergic innervation of adult neurogenic areas," Journal of Comparative Neurology, vol. 522, no. 10, pp. 2336-2348, 2014.
83. A. J. Eisch and C. D. Mandyam, "Adult neurogenesis: can analysis of cell cycle proteins move us 'beyond BrdU'?" Current Pharmaceutical Biotechnology, vol. 8, no. 3, pp. 147-165, 2007.
84. M. A. Curtis, V. F. Low, and R. L. M. Faull, "Neurogenesis and progenitor cells in the adult human brain: a comparison between hippocampal and subventricular progenitor proliferation," Developmental Neurobiology, vol. 72, no. 7, pp. 990-1005, 2012.
85. P. Taupin, "BrdU immunohistochemistry for studying adult neurogenesis: paradigms, pitfalls, limitations, and validation," Brain Research Reviews, vol. 53, no. 1, pp. 198-214, 2007.
86. A. Ernst, K. Alkass, S. Bernard et al., "Neurogenesis in the Striatumof the adult human brain," Cell, vol. 156, pp. 1072-1083, 2014.
87. M. L. Monje, H. Vogel, M. Masek, K. L. Ligon, P. G. Fisher, and T.D. Palmer, "Impaired human hippocampal neurogenesis after treatment for central nervous system malignancies," Annals of Neurology, vol. 62, no. 5, pp. 515-520, 2007.
88. R. W. H. Verwer, A. A. Sluiter, R. A. Balesar et al., "Mature astrocytes in the adult human neocortex express the early neuronal marker doublecortin," Brain, vol. 130, no. 12, pp. 3321-3335, 2007.